Rayence Co. Ltd (228850) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Rayence Co. Ltd (228850) has a cash flow conversion efficiency ratio of 0.022x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.23 Billion ≈ $3.55 Million USD) by net assets (₩237.37 Billion ≈ $160.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 228850 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Rayence Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Rayence Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Rayence Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rayence Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FALCON METALS LTD
F:E47
|
N/A |
|
Golden Energy Offshore Services AS
OL:GEOS
|
0.122x |
|
Gateway Real Estate AG
XETRA:GTY
|
-0.048x |
|
Nestcon Bhd
KLSE:0235
|
0.079x |
|
Jinhui Shipping and Transportation Limited
OL:JIN
|
0.038x |
|
Cheviot Company Limited
NSE:CHEVIOT
|
0.072x |
|
Kawan Food Bhd
KLSE:7216
|
0.001x |
|
Jayant Agro Organics Limited
NSE:JAYAGROGN
|
-0.075x |
Annual Cash Flow Conversion Efficiency for Rayence Co. Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Rayence Co. Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Rayence Co. Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩237.37 Billion ≈ $160.86 Million |
₩9.21 Billion ≈ $6.24 Million |
0.039x | -61.79% |
| 2024-12-31 | ₩244.67 Billion ≈ $165.81 Million |
₩24.84 Billion ≈ $16.83 Million |
0.102x | -5.32% |
| 2023-12-31 | ₩240.80 Billion ≈ $163.19 Million |
₩25.82 Billion ≈ $17.50 Million |
0.107x | +45.11% |
| 2022-12-31 | ₩224.75 Billion ≈ $152.31 Million |
₩16.61 Billion ≈ $11.25 Million |
0.074x | -29.22% |
| 2021-12-31 | ₩200.58 Billion ≈ $135.93 Million |
₩20.94 Billion ≈ $14.19 Million |
0.104x | -15.53% |
| 2020-12-31 | ₩188.17 Billion ≈ $127.52 Million |
₩23.25 Billion ≈ $15.76 Million |
0.124x | +154.02% |
| 2019-12-31 | ₩194.30 Billion ≈ $131.67 Million |
₩9.45 Billion ≈ $6.41 Million |
0.049x | -39.82% |
| 2018-12-31 | ₩181.86 Billion ≈ $123.25 Million |
₩14.70 Billion ≈ $9.96 Million |
0.081x | -30.74% |
| 2017-12-31 | ₩176.64 Billion ≈ $119.71 Million |
₩20.62 Billion ≈ $13.97 Million |
0.117x | +130.75% |
| 2016-12-31 | ₩165.42 Billion ≈ $112.10 Million |
₩8.37 Billion ≈ $5.67 Million |
0.051x | -67.47% |
| 2015-12-31 | ₩60.02 Billion ≈ $40.67 Million |
₩9.33 Billion ≈ $6.32 Million |
0.155x | -- |
About Rayence Co. Ltd
Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-… Read more